Aberrant calcium channel splicing drives defects in cortical differentiation in Timothy Syndrome

  1. Georgia Panagiotakos  Is a corresponding author
  2. Christos Haveles
  3. Arpana Arjun
  4. Ralitsa Petrova
  5. Anshul Rana
  6. Thomas Portmann
  7. Sergiu P Paşca
  8. Theo D Palmer
  9. Ricardo E Dolmetsch
  1. University of California, San Francisco, United States
  2. Stanford University School of Medicine, United States

Abstract

The syndromic autism spectrum disorder (ASD) Timothy Syndrome (TS) is caused by a point mutation in the alternatively spliced exon 8A of the calcium channel Cav1.2. Using mouse brain and human induced pluripotent stem cells (iPSCs), we provide evidence that the TS mutation prevents a normal developmental switch in Cav1.2 exon utilization, resulting in persistent expression of gain-of-function mutant channels during neuronal differentiation. In iPSC models, the TS mutation reduces the abundance of SATB2-expressing cortical projection neurons, leading to excess CTIP2+ neurons. We show that expression of TS-Cav1.2 channels in the embryonic mouse cortex recapitulates these differentiation defects in a calcium-dependent manner and that in utero Cav1.2 gain-and-loss of function reciprocally regulates the abundance of these neuronal populations. Our findings support the idea that disruption of developmentally-regulated calcium channel splicing patterns instructively alters differentiation in the developing cortex, providing important in vivo insights into the pathophysiology of a syndromic ASD.

Data availability

All data analyzed in this study have been included in the manuscript and supporting files and figures. Source data files have been provided for Figures 1 to 4, as well as Figure 1-figure supplement 1

Article and author information

Author details

  1. Georgia Panagiotakos

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    For correspondence
    georgia.panagiotakos@ucsf.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9444-2480
  2. Christos Haveles

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  3. Arpana Arjun

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  4. Ralitsa Petrova

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5586-6192
  5. Anshul Rana

    Graduate Program in Biochemistry, Stanford University School of Medicine, Stanford, United States
    Competing interests
    No competing interests declared.
  6. Thomas Portmann

    Department of Neurobiology, Stanford University School of Medicine, Stanford, United States
    Competing interests
    Thomas Portmann, is currently an employee of Neucyte, Inc.
  7. Sergiu P Paşca

    Department of Neurobiology, Stanford University School of Medicine, Stanford, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3216-3248
  8. Theo D Palmer

    Department of Neurosurgery, Stanford University School of Medicine, Stanford, United States
    Competing interests
    No competing interests declared.
  9. Ricardo E Dolmetsch

    Department of Neurobiology, Stanford University School of Medicine, Stanford, United States
    Competing interests
    Ricardo E Dolmetsch, is currently an employee of Novartis Institutes for Biomedical Research.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2738-8338

Funding

National Institutes of Health (F31 MH090648 Predoctoral Fellowship)

  • Georgia Panagiotakos

National Institutes of Health (R01 MH096815)

  • Theo D Palmer

National Institutes of Health (Pioneer Award 5DP1OD3889)

  • Ricardo E Dolmetsch

Stanford University School of Medicine (Frances B Nelson Neuroscience Graduate Fellowship)

  • Georgia Panagiotakos

University of California, San Francisco (Program for Breakthrough Biomedical Research Sandler Foundation)

  • Georgia Panagiotakos

Howard Hughes Medical Institute (International Student Research Award)

  • Anshul Rana

Stanford University School of Medicine (Lucile P Markey Graduate Fellowship)

  • Anshul Rana

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Postdoctoral Fellowship PBSKP3-123434)

  • Thomas Portmann

Brain and Behavior Research Foundation (NARSAD Young Investigator Award)

  • Sergiu P Paşca

Simons Foundation (SFARI 206574)

  • Theo D Palmer

Blume Foundation

  • Theo D Palmer

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Anita Bhattacharyya, University of Wisconsin, Madison, United States

Ethics

Animal experimentation: All animal experiments performed in this study were done so in accordance with the National Institutes of Health guidelines for the care and use of laboratory animals and protocols approved by the Stanford University and University of California, San Francisco (UCSF) Institutional Animal Care and Use Committees (Stanford protocol #13705 granted to the lab of Dr. Ricardo Dolmetsch, and UCSF protocol #AN109792 granted to the lab of Dr. Georgia Panagiotakos).

Human subjects: Collection of dermal fibroblasts from TS patients and unaffected control subjects, as well as iPSC generation was previously described (Pasca, et al. 2011). Experiments involving primary dermal fibroblasts and iPSCs from Timothy Syndrome patients and healthy control subjects were conducted at Stanford University under study protocols (#12481, #232, and #327) approved by the Institutional Review Board and Stem Cell Research Oversight (SCRO) committees of Stanford University after obtaining informed consent.

Version history

  1. Received: August 12, 2019
  2. Accepted: December 21, 2019
  3. Accepted Manuscript published: December 23, 2019 (version 1)
  4. Version of Record published: January 16, 2020 (version 2)

Copyright

© 2019, Panagiotakos et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,243
    views
  • 518
    downloads
  • 40
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Georgia Panagiotakos
  2. Christos Haveles
  3. Arpana Arjun
  4. Ralitsa Petrova
  5. Anshul Rana
  6. Thomas Portmann
  7. Sergiu P Paşca
  8. Theo D Palmer
  9. Ricardo E Dolmetsch
(2019)
Aberrant calcium channel splicing drives defects in cortical differentiation in Timothy Syndrome
eLife 8:e51037.
https://doi.org/10.7554/eLife.51037

Share this article

https://doi.org/10.7554/eLife.51037

Further reading

    1. Immunology and Inflammation
    2. Neuroscience
    Nicolas Aubert, Madeleine Purcarea ... Gilles Marodon
    Research Article

    CD4+CD25+Foxp3+ regulatory T cells (Treg) have been implicated in pain modulation in various inflammatory conditions. However, whether Treg cells hamper pain at steady state and by which mechanism is still unclear. From a meta-analysis of the transcriptomes of murine Treg and conventional T cells (Tconv), we observe that the proenkephalin gene (Penk), encoding the precursor of analgesic opioid peptides, ranks among the top 25 genes most enriched in Treg cells. We then present various evidence suggesting that Penk is regulated in part by members of the Tumor Necrosis Factor Receptor (TNFR) family and the transcription factor Basic leucine zipper transcription faatf-like (BATF). Using mice in which the promoter activity of Penk can be tracked with a fluorescent reporter, we also show that Penk expression is mostly detected in Treg and activated Tconv in non-inflammatory conditions in the colon and skin. Functionally, Treg cells proficient or deficient for Penk suppress equally well the proliferation of effector T cells in vitro and autoimmune colitis in vivo. In contrast, inducible ablation of Penk in Treg leads to heat hyperalgesia in both male and female mice. Overall, our results indicate that Treg might play a key role at modulating basal somatic sensitivity in mice through the production of analgesic opioid peptides.

    1. Neuroscience
    James Malkin, Cian O'Donnell ... Laurence Aitchison
    Research Article

    Biological synaptic transmission is unreliable, and this unreliability likely degrades neural circuit performance. While there are biophysical mechanisms that can increase reliability, for instance by increasing vesicle release probability, these mechanisms cost energy. We examined four such mechanisms along with the associated scaling of the energetic costs. We then embedded these energetic costs for reliability in artificial neural networks (ANNs) with trainable stochastic synapses, and trained these networks on standard image classification tasks. The resulting networks revealed a tradeoff between circuit performance and the energetic cost of synaptic reliability. Additionally, the optimised networks exhibited two testable predictions consistent with pre-existing experimental data. Specifically, synapses with lower variability tended to have (1) higher input firing rates and (2) lower learning rates. Surprisingly, these predictions also arise when synapse statistics are inferred through Bayesian inference. Indeed, we were able to find a formal, theoretical link between the performance-reliability cost tradeoff and Bayesian inference. This connection suggests two incompatible possibilities: evolution may have chanced upon a scheme for implementing Bayesian inference by optimising energy efficiency, or alternatively, energy-efficient synapses may display signatures of Bayesian inference without actually using Bayes to reason about uncertainty.